Search

The preliminary findings of an investigation into the innovation performance of Russia and Ukraine placed them 27th and 35th respectively out of 36 countries considered in the study.

Governments seek to encourage innovation in healthcare, but then they won’t pay for the treatments that follow. But who are they to judge?

It’s not enough to spin companies out and build them as national enterprises, says Imperial College Pro Rector Tidu Maini. The challenge is to go global – we need to scale up our thinking on science.

US dominance in innovation can no longer be assumed, believe the CEOs of some of its leading technology companies. Competitiveness is set to be a key issue in the 2008 Presidential election

In swelling its partners from 20 in 2000 to over 1,300 today, IBM has proved that its venture-partnering model can yield terrific results.

North Rhine–Westphalia’s Industrial Biotechnology Cluster took joint honours with the Hamburg region in German’s BioIndustry 2021 competition.

Is medical research worth the money? The UK Medical Research Council has commissioned to find out the answer.

A survey of applications filed at the European Patent Office finds the field of nanotechnology is splintered across a vast array of application areas.

After a decade of withering in the shade of genetically modified crops, plant sciences are back on the political agenda in Europe follow the launch this week of a new Strategic Research Agenda.

The European Union inched closer to creating a European Institute of Technology this week, when ministers to dedicate up to €308.7 million to the project.

The EIT finally squeaks through the Brussels bureaucracy – but more dead than alive

Innovation policy focuses on technology-driven industries such as electronics and pharmaceuticals. But it’s happening elsewhere too.

The United Kingdom is the leading knowledge economy according to the London-based think tank, The Work Foundation.

India’s biotech sector is powering ahead, with 30 per cent annual growth over the past four years. But venture capitalists are still not tempted to invest.